Led by Associate Professor Therese Becker, the Centre for CTC Diagnostics & Research (CCDR) study circulating tumour cells (CTCs) and circulating tumor DNA (ctDNA). Using blood samples from cancer patients, the CCDR team analyse these samples using the highly sensitive methods they have developed in order to achieve the following:
- To aid personalised cancer therapy by enabling the detection of clinically important cancer biomarkers from blood samples.
- To establish blood-based techniques to monitor cancer therapy response.
Ultimately, this helps to tailor cancer treatment using non-invasive, economical techniques.